October 31, 2024

Orbit advises 415 Capital on the launch of its EUR 150m Med-Tech VC Fund II.

415 Capital, a global leader in medical technology venture capital, has launched its second fund, 415 Capital Fund II, with a target volume of EUR 150 million. The fund will focus on advancing life-saving technologies to treat cardiovascular and neurovascular diseases.

Early investors include prominent limited partners such as the European Investment Fund (EIF), KfW Capital, and Wachstumsfonds Deutschland, along with several reputable family offices from Europe and North America.

The GP advisory team at Orbit advised 415 Capital on all legal, tax, and regulatory aspects of the structuring, marketing and closings of the fund.

Team

Dr. Philip Mostertz (Partner, Fund Structuring) Michael Schnitker (Senior Fund Associate, Fund Structuring), Marven Unewisse (Fund Associate, Fundraising, Compliance), Louise Hertz (Fund Associate, SFDR, Regulatory), and Frank Pluskat (Fund Counsel, Corporate).

Related links

415 Capital Announces €150 Million Second Fund and Key Appointments to Investment Committee to Support Breakthrough and Life-Saving Medical Innovation

415 Capital gibt neuen 150-Millionen-Euro-Fonds und Erweiterung des Investitionsausschusses zur Förderung bahnbrechender und lebensrettender Medizintechnologien bekannt (PR Newswire)

About 415 Capital

415 Capital is a leading venture capital firm specializing in medical technology investments across Europe, the U.S., and Israel. Headquartered in Munich, Germany, the firm manages nearly USD 200m in assets and focuses on clinical-stage innovations addressing cardiovascular and neurovascular diseases, the leading causes of death and disability globally and the top drivers of healthcare costs. Additionally, 415 Capital selectively invests in neuromodulation, medical robotics, and companies innovating at the intersection of patient monitoring, medical imaging, and Artificial Intelligence (AI). Visit the website for more information: 415 Capital

About Orbit

Orbit offers client-centered legal advice in all areas of fund law and investments in alternative assets. Fund managers and investors rely on Orbit and its team of experienced fund advisors. Orbit covers structuring, regulatory, tax, investment advice, compliance, and fund due diligence as well as secondary transactions.

Orbit | All. About. Funds.

Responsible Orbit Crew

Dr. Philip Mostertz

Founder and Partner
Lead
,
Fund Structuring
,

Michael Schnitker

Senior Fund Associate
Fund Structuring
,

Marven Unewisse

Fund Associate
Compliance
,
Fundraising
,

Louise Hertz

Fund Associate
SFDR
,
Regulatory
,

Frank Pluskat

Fund Counsel
Corporate
,

Reach out to Orbit.

Orbit offers client-centered legal advice in all areas of fund law and investments in alternative assets. Profound and pragmatic. Fund managers and investors rely on Orbit and its team of experienced fund advisors.

We got you covered on structuring, regulatory, tax, investment advice and fund due diligence. Client-centered fund advisory. Become our gravitational focus!

Get In Touch
Space rocket flying few moments after launching